SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-011375
Filing Date
2022-08-15
Accepted
2022-08-15 16:23:27
Documents
56
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q drma_10q.htm   iXBRL 10-Q 966163
2 THIRD AMENDMENT TO EMPLOYMENT AGREEMENT drma_ex104.htm EX-10.4 7658
3 CERTIFICATION drma_ex311.htm EX-31.1 12504
4 CERTIFICATION drma_ex312.htm EX-31.2 12723
5 CERTIFICATION drma_ex321.htm EX-32.1 7986
  Complete submission text file 0001654954-22-011375.txt   4531051

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA drma-20220630.xsd EX-101.SCH 54621
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20220630_lab.xml EX-101.LAB 277325
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20220630_cal.xml EX-101.CAL 27274
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20220630_pre.xml EX-101.PRE 236980
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20220630_def.xml EX-101.DEF 165186
50 EXTRACTED XBRL INSTANCE DOCUMENT drma_10q_htm.xml XML 634313
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40739 | Film No.: 221165956
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences